A Smedowski
Medical University of Silesia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by A Smedowski.
Investigative Ophthalmology & Visual Science | 2014
A Smedowski; B Weglarz; Dorota Tarnawska; Kai Kaarniranta; Edward Wylegala
PURPOSE The aim of this study was to show the usefulness of three methods for measuring IOP: Goldmann applanation tonometry, rebound tonometry, and Ultra-High-Speed Scheimpflug technology. METHODS The examined group consisted of 96 patients (192 eyes), including 63 women and 33 men with a mean age of 59.3 ± 19.9 years. Together, 152 healthy eyes and 40 eyes with different pathologies were examined. Intraocular pressure was measured using the Goldmann applanation tonometer (GAT), the Icare Pro rebound tonometer (RT), and Ultra-High-Speed Scheimpflug technology (UHS ST; Corvis ST with pachymetry). Additionally, corneal pachymetry was conducted with a Scheimpflug camera (Pentacam) and an Ultrasound Pachymeter (A-scan Plus) as a comparison for Corvis ST pachymetry. RESULTS The mean IOPs were 15.6 ± 3.75 mm Hg, 15.6 ± 3.5 mm Hg, and 16.1 ± 4.0 mm Hg when measured with the GAT, the RT, and the UHS ST, respectively. The mean central corneal thickness (CCT) was 543.7 ± 52.7 μm, 547.9 ± 54.0 μm, and 556.25 ± 38.8 μm as measured with the UHS ST, the Pentacam, and the Ultrasound Pachymeter, respectively. In comparison between devices, there was a significant difference between IOP values measured with the GAT and the RT versus the UHS ST (P < 0.001), and there was no significant difference between GAT and RT (P = 0.5). No significant differences were observed in CCT measured with the UHS ST, Pentacam, and Ultrasound Pachymeter. CONCLUSIONS We showed that the RT Icare Pro ensures IOP measurements that are more comparable with the measurements obtained with the GAT than the measurements that are provided by UHS ST.
Scientific Reports | 2015
A Smedowski; Marita Pietrucha-Dutczak; Kai Kaarniranta; Joanna Lewin-Kowalik
Glaucoma is a chronic disease that causes structural and functional damage to retinal ganglion cells (RGC). The currently employed therapeutic options are not sufficient to prevent vision loss in patients with glaucoma; therefore, there is a need to develop novel therapies, which requires the creation of functional, repeatable and easy-to-utilize animal models for use in pre-clinical studies. The currently available models ensure only low to moderate damage in optic nerves, with high variation in the outcomes and poor repeatability. We have developed an effective and reproducible rat glaucoma model based on a previous idea for a “Bead Model” in mice, which could be useful in future glaucoma research. Additionally, in an attempt to achieve rapid elevation of Intraocular Pressure (IOP), we included an initial “high-pressure injury” as part of this method, which serves as the equivalent of a severe glaucoma attack. These modifications made it possible to achieve longer lasting IOP elevation with chronic damage of retinal ganglion cells.
Cornea | 2014
Pasquale Aragona; Edward Wylegala; Ewa Wroblewska-Czajka; A Smedowski; Anna Nowinska; Anna M. Roszkowska; Antonina Pisani; Antonio Micali; Domenico Puzzolo
Purpose: The aim was to describe the confocal and histological findings of 2 corneas from a patient with an advanced case of type I mucopolysaccharidoses Hurler–Scheie disease (MPS IH-S). Methods: Both corneas from an MPS IH-S–affected patient were examined in vivo using confocal microscopy and then removed and processed for evaluation using light microscopy and transmission and scanning electron microscopy. Results: Confocal microscopy evaluation showed basal epithelial cells with either diffuse or granular hyperreflectivity. Keratocytes were highly reflective determining a web-shaped stromal appearance. Endothelial cells were barely visible. The histopathological study demonstrated superficial cells with apical microfolds, small vesicles, and evident intercellular junctions. The wing cells showed either well-evident tonofilaments and small peripheral vesicles, or large paranuclear vesicles. The basal cells showed polygonal shapes, many small vesicles, and enlarged intercellular spaces. The Bowman layer was either normal or thinner and was formed by variably electron dense material. In the stroma, irregularly oriented lamellae, many vesicle-filled keratocytes, and intercellular granular material were present. The Descemet membrane was normal, whereas the corneal endothelium showed marked degenerative changes. Conclusions: The confocal alterations appeared consequent to the anomalous accumulation of material. The histopathological images gave a clue to better understand the corneal changes demonstrated by the confocal studies in MPS IH-S.
Scientific Reports | 2016
A Smedowski; Xiaonan Liu; Marita Pietrucha-Dutczak; Iwona Matuszek; Markku Varjosalo; Joanna Lewin-Kowalik
Glaucoma is an optic neuropathy that leads to irreversible blindness. Because the current therapies are not sufficient to protect against glaucoma-induced visual impairment, new treatment approaches are necessary to prevent disease progression. Cell transplantation techniques are currently considered to be among the most promising opportunities for nervous system damage treatment. The beneficial effects of undifferentiated cells have been investigated in experimental models of glaucoma, however experiments were accompanied by various barriers, which would make putative treatment difficult or even impossible to apply in a clinical setting. The novel therapy proposed in our study creates conditions to eliminate some of the identified barriers described for precursor cells transplantation and allows us to observe direct neuroprotective and pro-regenerative effects in ongoing optic neuropathy without additional modifications to the transplanted cells. We demonstrated that the proposed novel Schwann cell therapy might be promising, effective and easy to apply, and is safer than the alternative cell therapies for the treatment of glaucoma.
Oxidative Medicine and Cellular Longevity | 2018
Nicoletta Marchesi; Natthakan Thongon; Alessia Pascale; Alessandro Provenzani; Ali Koskela; Eveliina Korhonen; A Smedowski; Stefano Govoni; Anu Kauppinen; Kai Kaarniranta; Marialaura Amadio
RNA-binding protein dysregulation and altered expression of proteins involved in the autophagy/proteasome pathway play a role in many neurodegenerative disease onset/progression, including age-related macular degeneration (AMD). HuR/ELAVL1 is a master regulator of gene expression in human physiopathology. In ARPE-19 cells exposed to the proteasomal inhibitor MG132, HuR positively affects at posttranscriptional level p62 expression, a stress response gene involved in protein aggregate clearance with a role in AMD. Here, we studied the early effects of the proautophagy AICAR + MG132 cotreatment on the HuR-p62 pathway. We treated ARPE-19 cells with Erk1/2, AMPK, p38MAPK, PKC, and JNK kinase inhibitors in the presence of AICAR + MG132 and evaluated HuR localization/phosphorylation and p62 expression. Two-hour AICAR + MG132 induces both HuR cytoplasmic translocation and threonine phosphorylation via the Erk1/2 pathway. In these conditions, p62 mRNA is loaded on polysomes and its translation in de novo protein is favored. Additionally, for the first time, we report that JNK can phosphorylate HuR, however, without modulating its localization. Our study supports HuRs role as an upstream regulator of p62 expression in ARPE-19 cells, helps to understand better the early events in response to a proautophagy stimulus, and suggests that modulation of the autophagy-regulating kinases as potential therapeutic targets for AMD may be relevant.
Oxidative Medicine and Cellular Longevity | 2018
A Smedowski; Marita Pietrucha-Dutczak; Ruchi Maniar; Michael Ajeleti; Iwona Matuszek; Joanna Lewin-Kowalik
Preclinical toxicity screening of the new retinal compounds is an absolute requirement in the pathway of further drug development. Since retinal neuron cultivation and in vivo studies are relatively expensive and time consuming, we aimed to create a fast and reproducible ex vivo system for retinal toxicity screening. For this purpose, we used rat retinal explant culture that was retrogradely labeled with the FluoroGold before the isolation. Explants were exposed to a toxic concentration of gentamicin and ciliary neurotrophic factor (CNTF), a known neuroprotective agent. The measured outcomes showed the cell density in retinal ganglion cell layer (GCL) and the activity of lactate dehydrogenase (LDH) in the culture medium. Gentamicin-induced oxidative stress resulted in retinal cell damage and rapid LDH release to the culture medium (p < 0.05). Additional CNTF supplementation minimized the cell damage, and the increase of LDH release was insignificant when compared to LDH levels before gentamicin insult (p > 0.05). As well as this, the LDH activity was directly correlated with the cell count in GCL (R = −0.84, p < 0.00001), making a sensitive marker of retinal neuron damage. The FLOREC protocol could be considered as a fast, reproducible, and sensitive method to detect neurotoxicity in the screening studies of the retinal drugs.
Biochimica et Biophysica Acta | 2018
A Smedowski; Xiaonan Liu; Lucia Podracka; Saeed Akhtar; Anna Trzeciecka; Marita Pietrucha-Dutczak; Joanna Lewin-Kowalik; Arto Urtti; Marika Ruponen; Kai Kaarniranta; Markku Varjosalo; Marialaura Amadio
The RNA-binding protein, HuR, modulates mRNA processing and gene expression of several stress response proteins i.e. Hsp70 and p53 that have been postulated to be involved in the pathogenesis of glaucoma, a chronic optic neuropathy leading to irreversible blindness. We evaluated HuR protein expression in retinas and optic nerves of glaucomatous rats and human primary open angle glaucoma patients and its possible impact on stress response mechanisms. We found that the cytoplasmic content of HuR was reduced more extensively in glaucomatous retinas than in optic nerves and this was linked with a declined cytoplasmic Hsp70 level and p53 nuclear translocation. In the optic nerve, the p53 content was decreased as a feature of reactive gliosis. Based on our findings, we conclude that the alteration in the HuR content, observed both in rat glaucoma model and human glaucoma samples, affects post-transcriptionally the expression of genes crucial for maintaining cell homeostasis; therefore, we postulate that HuR may be involved in the pathogenesis of glaucoma.
Scientific Reports | 2017
Marita Pietrucha-Dutczak; A Smedowski; Xiaonan Liu; Iwona Matuszek; Markku Varjosalo; Joanna Lewin-Kowalik
Glaucoma is thought to be the main cause of severe visual impairment or permanent loss of vision. Current therapeutic strategies are not sufficient to protect against glaucoma. Thus, new therapies and potential novel therapeutic targets must be developed to achieve progress in the treatment of this insidious disease. This study was undertaken to verify whether the time of administration of an extract from predegenerated rat sciatic nerves as well as exposure time of this extract onto retinal ganglion cells (RGCs) influences the survival of RGCs in a rat glaucoma model. We have demonstrated that extract obtained from the predegenerated sciatic nerves protects RGCs in a rat glaucoma model. The neuroprotective effect depends mostly on the time of administration of the extract and less clearly on the time of exposure to the extract and is associated with stimulation of endogenous BDNF expression both in RGCs and glial cells. The 14th day following glaucoma induction represents a therapeutic window for effective treatment in a glaucoma model. Mass Spectrometry analysis demonstrated that metallothionein 2 (MT2) may be a key molecule responsible for neuroprotective effects on RGC survival.
Histology and Histopathology | 2015
Kai Kaarniranta; Eszter Szalai; A Smedowski; Zoltán Hegyi; Niko Kivinen; Johanna Viiri; Bogumil Wowra; Dariusz Dobrowolski; László Módis; András Berta; Edward Wylegala; Szabolcs Felszeghy
Macular corneal dystrophy is a rare autosomal recessive eye disease affecting primarily the corneal stroma. Abnormal accumulation of proteoglycan aggregates has been observed intra- and extracellularly in the stromal layer. In addition to the stromal keratocytes and corneal lamellae, deposits are also present in the basal epithelial cells, endothelial cells and Descemets membrane. Misfolding of proteins has a tendency to gather into aggregating deposits. We studied interaction of molecular chaperones and proteasomal clearance in macular dystrophy human samples and in human corneal HCE-2 epithelial cells. Seven cases of macular corneal dystrophy and four normal corneal buttons collected during corneal transplantation were examined for their expression patterns of heat shock protein 70, ubiquitin protein conjugates and SQSTM1/p62. In response to proteasome inhibition the same proteins were analyzed by western blotting. Slit-lamp examination, in vivo confocal cornea microscopy and transmission electron microscopy were used for morphological analyses. Heat shock protein 70, ubiquitin protein conjugates and SQSTM1/p62 were upregulated in both the basal corneal epithelial cells and the stromal keratocytes in macular corneal dystrophy samples that coincided with an increased expression of the same molecules under proteasome inhibition in the HCE-2 cells in vitro. We propose a novel regulatory mechanism that connects the molecular chaperone and proteasomal clearance system in the pathogenesis of macular corneal dystrophy.
Redox biology | 2019
Szabolcs Felszeghy; Johanna Viiri; Jussi J. Paterno; Juha M.T. Hyttinen; Ali Koskela; Mei Chen; Henri Leinonen; Heikki Tanila; Niko Kivinen; Arto Koistinen; Elisa Toropainen; Marialaura Amadio; A Smedowski; Mika Reinisalo; Mateusz Winiarczyk; Jerzy Mackiewicz; Maija Mutikainen; Anna Kaisa Ruotsalainen; Mikko I. Kettunen; Kimmo T. Jokivarsi; Debasish Sinha; Kati Kinnunen; Goran Petrovski; Janusz Blasiak; Geir Bjørkøy; Ari Koskelainen; Heli Skottman; Arto Urtti; Antero Salminen; Ram Kannan
Age-related macular degeneration (AMD) is a multi-factorial disease that is the leading cause of irreversible and severe vision loss in the developed countries. It has been suggested that the pathogenesis of dry AMD involves impaired protein degradation in retinal pigment epithelial cells (RPE). RPE cells are constantly exposed to oxidative stress that may lead to the accumulation of damaged cellular proteins, DNA and lipids and evoke tissue deterioration during the aging process. The ubiquitin-proteasome pathway and the lysosomal/autophagosomal pathway are the two major proteolytic systems in eukaryotic cells. NRF-2 (nuclear factor-erythroid 2-related factor-2) and PGC-1α (peroxisome proliferator-activated receptor gamma coactivator-1 alpha) are master transcription factors in the regulation of cellular detoxification. We investigated the role of NRF-2 and PGC-1α in the regulation of RPE cell structure and function by using global double knockout (dKO) mice. The NRF-2/PGC-1α dKO mice exhibited significant age-dependent RPE degeneration, accumulation of the oxidative stress marker, 4-HNE (4-hydroxynonenal), the endoplasmic reticulum stress markers GRP78 (glucose-regulated protein 78) and ATF4 (activating transcription factor 4), and damaged mitochondria. Moreover, levels of protein ubiquitination and autophagy markers p62/SQSTM1 (sequestosome 1), Beclin-1 and LC3B (microtubule associated protein 1 light chain 3 beta) were significantly increased together with the Iba-1 (ionized calcium binding adaptor molecule 1) mononuclear phagocyte marker and an enlargement of RPE size. These histopathological changes of RPE were accompanied by photoreceptor dysmorphology and vision loss as revealed by electroretinography. Consequently, these novel findings suggest that the NRF-2/PGC-1α dKO mouse is a valuable model for investigating the role of proteasomal and autophagy clearance in the RPE and in the development of dry AMD.